Contribute Try STAT+ Today

drug pricing

Most Read

John Arnold

Health By Lev Facher

How a billionaire couple greased the skids for Nancy Pelosi’s drug pricing bill

Frank Pallone

Exclusive By Rachel Cohrs

House Democrats slip drug pricing proposal into Covid-19 relief bill

Election 2020 First Debate

Politics By Nicholas Florko

Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before

Nathan Yates

First Opinion By Nathan Yates

I have spinal muscular atrophy. Critics of the $2 million new gene therapy are missing the point

drug therapies illo concept

First Opinion By William S. Smith

The Biden administration needs to look beyond ICER for evaluating drug therapies

medication overload

Pharmalot By Ed Silverman

The CEO of Mark Cuban’s generics company talks drug prices, manufacturing, and his famous boss

Pharmacy shelves

Pharmalot By Ed Silverman

Pharmacy benefit managers take heavy criticism from a new source: local officials

Biden Friday

Politics By Rachel Cohrs

Biden administration pumps brakes on signature Trump drug pricing proposal

All Coverage

maple leaf pills

Politics By Lev Facher

States still can’t import drugs from Canada. Now, many are seeking to import Canadian prices

antibiotics/teal background

Pharmalot By Ed Silverman

Once again, senators want GAO to probe the role of PBMs in prescription drug pricing

advertisement

med pills shopping cart rebates

Pharmalot By Ed Silverman

With a legislative vote, Maryland’s prescription drug affordability board moves forward

Colorful selection of pills

Pharmalot By Ed Silverman

Drug maker will slash prices on cancer medicines to end price gouging probe in Europe

Pharmalot By Ed Silverman

Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug

Drug Prices TV Ads

Pharmalot By Ed Silverman

U.S. drug prices were more than double those in dozens of countries in 2018

White pills on yellow background

Pharmalot By Ed Silverman

Pharma is only ‘inching forward’ in boosting access to medicines in low-income countries

PBM pharmacy pill costs

Pharmalot By Ed Silverman

This academic published a manual for using a little-known federal law for lowering drug prices

Canada drugs

Pharmalot By Ed Silverman

Canada’s drug makers rattle their sabers over a government plan to control medicine spending

med pills shopping cart rebates

Pharmalot By Ed Silverman

How much? Hospitals mark up some medicines by 250% on average

Federal Trade Commission

Pharmalot By Ed Silverman

Will the FTC get tougher on pharma business practices under the Biden administration?

Drug pricing

Pharmalot By Ed Silverman

Maryland Senate overrides governor’s veto of prescription drug affordability board

PBM pharmacy pill costs

Pharmalot By Ed Silverman

Medicare Part D spent twice what the VA paid for the same drugs

AstraZeneca building

Pharma By Ed Silverman

Drug makers sue HHS over a discount program serving low-income populations

Mark Cuban

Pharmalot By Ed Silverman

Mark Cuban wades into the generic drug shark tank with a new company

Insulin in Minnesota

Pharmalot By Ed Silverman

Endocrinologists urge federal lawmakers to act to lower insulin costs

Trump drug prices Alex Azar

Politics By Nicholas Florko

Middlemen sue to block a signature Trump drug pricing proposal

Pills price rebate

Pharmalot By Ed Silverman

The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2019

White pills on blue

Pharmalot By Ed Silverman

Commerce Department agency proposes eliminating ‘march-in rights’ as a tool to lower drug prices

Drug Pricing

Biotech By Matthew Herper

Company dedicated to cutting drug prices raises lots of money, releases few details

Democrat Drug Price Rebuttal

Politics By Nicholas Florko and Lev Facher

Democrats have their best shot yet at letting Medicare negotiate drug prices — but it’s still not a done deal

Off-label Discussions

Pharmalot By Ed Silverman

Tennessee to become the first state to run a closed Medicaid drug formulary

Generic pills on red background

Pharmalot By Ed Silverman

Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat

Pill graph drug approval

Pharmalot By Ed Silverman

Pharma rings in the new year with 5% price hikes on hundreds of medicines

3 trends to watch in pharma

Pharmalot By Ed Silverman

3 pharma trends to watch in 2021